Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1261
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

SYMPOSIUM: LUNG CANCER

Gemcitabine in brief versus prolonged low-dose infusion, both combined with carboplatin for advanced non-small cell lung cancer

Beniwal S K, Patel K M, Shukla S, Parikh B J, Shah S, Patel A

Year : 2012| Volume: 49| Issue : 2 | Page no: 202-208

   This article has been cited by
 
1 Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer
Vijay Patil,Vanita Noronha,Amit Joshi,Anuradha Chougule,Sadhana Kannan,Atanu Bhattacharjee,Supriya Goud,Sucheta More,Arun Chandrasekharan,Nandini Menon,Sujay Srinivas,Dilip Harindran Vallathol,Hollis Dsouza,Swaratika Majumdar,Sudeep Das,Abhinav Zawar,Satvik Khaddar,Amit Kumar,Gunjesh Singh,Kanteti Aditya Pavan Kumar,Rahul Ravind,Vaishakhi Trivedi,Vichitra Behel,Abhishek Mahajan,Amit Janu,Nilendu Purandare,Kumar Prabhash
EClinicalMedicine. 2019; 9: 19
[Pubmed]  [Google Scholar] [DOI]
2 Meta-analysis of gemcitabine in brief versus prolonged low-dose infusion for advanced non-small cell lung cancer
Zhao Dehua,Chu Mingming,Wang Jisheng,Christina L. Addison
PLOS ONE. 2018; 13(3): e0193814
[Pubmed]  [Google Scholar] [DOI]
3 Gemcitabine-(5'-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549)
Cody P. Coyne,Lakshmi Narayanan
Chemical Biology & Drug Design. 2017; 89(3): 379
[Pubmed]  [Google Scholar] [DOI]
4 Combination of low-dose gemcitabine in 6-hour infusion and carboplatin is a favorable option for patients in poor performance status with advanced non-small cell lung cancer
Zhi-Yong Wu,Hui-Hong Guan,Ze-Xiao Lin,Hong-Kai Yang,Lan Zhou,Qi-Chun Cai
Journal of Chemotherapy. 2014; 26(5): 306
[Pubmed]  [Google Scholar] [DOI]
5 Low-dose gemcitabine in long infusion: When less is more
Zwitter, M.
Indian Journal of Cancer. 2012; 49(2): 199-201
[Pubmed]  [Google Scholar]
6 Optimizing patient outcome: Of equal importance in the palliative setting
Parikh, P. and Narayanan, P. and Bhattacharyya, Gs.
Indian Journal of Cancer. 2012; 49(3): 255-259
[Pubmed]  [Google Scholar]

 

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow